Masimo: EPS Exceeds Forecasts, Risks Up
Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.
Apple Wins a Whopping $250 Against Masimo Over Watch Patents
Apple has sought an injunction against health tech maker Masimo’s own smart watches, but it also netted the bare minimum for ...
Fintel on MSN3d
Raymond James Upgrades Masimo (MASI)
Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
pharmaphorum10d
Apple wins in Masimo lawsuit, but it's a shallow victory
In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...
Masimo (MASI): A Promising Medical Stock with Growth Potential
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
Business Wire12d
Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion
The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET ® pulse oximetry ... innovative measurements, sensors, patient monitors, and ...
Apple Secures Victory In Masimo Patent Dispute With Token Damages Of $250
A Delaware jury has ruled in favor of Apple in a patent infringement case against Masimo, awarding Cupertino a symbolic $250 ...
Apple wins patent lawsuit (and $250) from Masimo — but it won’t affect Apple Watch’s MIA blood oxygen feature
In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer ...
Tom's Guide15d
Apple wins patent lawsuit (and $250) from Masimo — but it won’t affect Apple Watch’s MIA blood oxygen feature
In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer Masimo ... on its patent for pulse oximetry. Between December 21 ...